HOUSTON, May 9, 2019 /PRNewswire/ -- Soliton, Inc.
(NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device
company with a novel and proprietary platform technology licensed
from The University of Texas on behalf
of the MD Anderson Cancer Center ("MD Anderson"), today reaffirmed
that its Executive Chairman, Walter
Klemp, will give a live interview on Yahoo Finance on
Monday, May 13, 2019.
As the Company has previously announced, data from its recently
completed proof-of-concept clinical trial to study the safety and
efficacy of a new version of its acoustic shockwave device for the
treatment of moderate to severe cellulite will be presented to the
scientific community at a national aesthetics conference, SCALE
2019 on May 11, 2019. This interview
with Yahoo Finance will cover this new data and what it means for
Soliton going forward.
Join our more than 200K fans here
to follow the Company: https://soly-investors.com
"We're pleased that Yahoo Finance has selected us to be featured
on their new live streaming network on 'The First Trade' on
Monday, May 13, 2019 between
9AM – 10AM
ET," commented Walter Klemp,
Executive Chairman of Soliton, Inc. "The focus will be to review
our newly released cellulite clinical trial data. Yahoo Finance has
a global audience of more than 90 million users each month and
we're excited to have the chance to discuss what the future may
have in store for Soliton!"
About Soliton, Inc.
Soliton, Inc. is a medical device company with a novel and
proprietary platform technology licensed from MD Anderson. The
Company's first planned commercial product is designed to use rapid
pulses of designed acoustic shockwaves in conjunction with existing
lasers to accelerate the removal of unwanted tattoos (RAP device).
In addition, higher energy versions of acoustic pulse devices are
in early stages of development for potential stand-alone treatment
of cellulite and other indications. Both products are
investigational and are not available for sale in the United States.
For more information about the Company, please
visit: http://www.soliton.com
Forward-Looking Statements
Some of the statements in this release are forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934 and the
Private Securities Litigation Reform Act of 1995, which involve
risks and uncertainties. Forward-looking statements in this press
release include, without limitation, viewership for 'The First
Trade' on Yahoo Finance and the ability of Soliton's acoustic
shockwave device to reduce cellulite in the proof of concept
clinical trial. These statements relate to future events, future
expectations, plans and prospects. Although Soliton believes that
the expectations reflected in such forward-looking statements are
reasonable as of the date made, expectations may prove to have been
materially different from the results expressed or implied by such
forward-looking statements. Soliton has attempted to identify
forward-looking statements by terminology including ''believes,''
''estimates,'' ''anticipates,'' ''expects,'' ''plans,''
''projects,'' ''intends,'' ''potential,'' ''may,'' ''could,''
''might,'' ''will,'' ''should,'' ''approximately'' or other words
that convey uncertainty of future events or outcomes to identify
these forward-looking statements. These statements are only
predictions and involve known and unknown risks, uncertainties, and
other factors, including those discussed under in our SEC filings,
including under the heading "Item 1A. Risk Factors" in the Form
10-K for year ended December 31, 2018
we filed with the SEC and updated from time to time in our Form
10-Q filings and in our other public filings with the SEC. Any
forward-looking statements contained in this release speak only as
of its date. Soliton undertakes no obligation to update any
forward-looking statements contained in this release to reflect
events or circumstances occurring after its date or to reflect the
occurrence of unanticipated events.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/soliton-to-be-featured-on-yahoo-finances-the-first-trade-show-on-may-13-2019-to-discuss-cellulite-trial-results-300846821.html
SOURCE Soliton, Inc.